Implications of population growth on prevalence of diabetes. A look at the future
- PMID: 1559424
- DOI: 10.2337/diacare.15.1.s6
Implications of population growth on prevalence of diabetes. A look at the future
Abstract
The purpose of this study was to present projections of the future population of diabetes patients, to discuss policy implications of these projections, and to suggest ways that these projections might be made more useful to medical professionals. Under the assumption that the incidence of diabetes in four age-groups will remain constant in future years, previous estimates of the incidence of diabetes will be applied to Bureau of the Census population projections to project the number of new cases of diabetes that can be expected in future years in each of these age-groups. The prevalence of diabetes will remain relatively constant at approximately 1 million patients in younger populations (less than 45 yr old) through the middle of the next century. As the post-World War II baby boom ages, the number of older diabetes patients (45 and older) will almost double from 6.5 million in 1987 to an estimated 11.6 million in the year 2030. Although there is little doubt that the aging of the population will increase the number of diabetes patients, the assumption of constant incidence rates is a very limiting one. These projections would be more useful for the planning of research and training if the incidence of diabetes could be estimated for more refined categories of demographic and medical characteristics.
PIP: A 1987 US study cited the prevalence of diabetes as 26.8 patients/1000 population. Using the Census Bureau's population projections of these same age groups until the year 2050 based on their middle mortality assumptions, projections of the number of diabetes patients by age-group are obtained by multiplying with the prevalence rates. These projections indicate that the number of diabetes patients 25 years of age will remain almost constant in the next 1/2 century, whereas the number between 25 and 45 will decline from a high of 983,000 in 1995 to a low of 870,000 in 2040. The number of patients in the 45-64 age group is projected to rise from 2.4 million in 1990 to 4.1 million in 2015, i.e., about 69,000 additional patients/year for the next 25 years. Those aged or= 65 years with the highest prevalence are projected to increase by an average of 55,000 new patients/year. For the following period of 2015-35 this oldest group of patients is projected to increase by an average of 120,000 patients/year. This is under the overly pessimistic assumption that there will be no scientific or medical discoveries to reduce the prevalence of diabetes. There are some implications for the diabetes community if the population of patients increases by over 1 million in the next decade and by over 3.7 million by 2020. Although the number of diabetes patients 65 will grow steadily for the next 20 years, the highest growth rates will be in the 45-64 age group. This implies that the number of qualified professionals may have to be increased and more emphasis directed to initial diagnosis and treatment. After the year 2010, the rate of growth of diabetes patients age 65 or older can be expected to accelerate compared with other age groups. These projections stress the importance of prevention and education. The requisite change in life style, exercise, or nutrition habits will be more difficult than if a drug is developed for treatment.
Similar articles
-
Household saving and demographic change, 1950-2050.Res Popul Econ. 1984;5:217-33. Res Popul Econ. 1984. PMID: 12266414
-
Projecting the impact of AIDS on mortality.AIDS. 1998;12 Suppl 1:S29-39. AIDS. 1998. PMID: 9677187 Review.
-
Faster growth, more diversity in U.S. projections.Popul Today. 1993 Feb;21(2):3, 10. Popul Today. 1993. PMID: 12286198
-
Population projections for Myanmar, 1983-2013.Asia Pac Popul J. 1991 Jun;6(2):21-54. Asia Pac Popul J. 1991. PMID: 12284415
-
The third age, the Third World and the third millennium.Contraception. 1996 Jan;53(1):1-7. doi: 10.1016/0010-7824(95)00258-8. Contraception. 1996. PMID: 8631183 Review.
Cited by
-
Determinants of coronary vascular disease in patients with type II diabetes mellitus and their therapeutic implications.Clin Cardiol. 1997 May;20(5):433-40. doi: 10.1002/clc.4960200506. Clin Cardiol. 1997. PMID: 9134273 Free PMC article. Review.
-
Identifying populations at high risk for diabetes with the Behavioral Risk Factor Surveillance System, Rhode Island, 2003.Prev Chronic Dis. 2010 Jul;7(4):A86. Epub 2010 Jun 15. Prev Chronic Dis. 2010. PMID: 20550844 Free PMC article.
-
A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050.Health Care Manag Sci. 2003 Aug;6(3):155-64. doi: 10.1023/a:1024467522972. Health Care Manag Sci. 2003. PMID: 12943151
-
Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review.Drugs Aging. 1994 Jun;4(6):470-91. doi: 10.2165/00002512-199404060-00004. Drugs Aging. 1994. PMID: 8075474 Review.
-
Projecting the future diabetes population size and related costs for the U.S.Diabetes Care. 2009 Dec;32(12):2225-9. doi: 10.2337/dc09-0459. Diabetes Care. 2009. PMID: 19940225 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials